Figure 1.Inhibition effect of hsa-miR-134-5p on the proliferation of glioma cells. (A) The expression of hsa-miR-134-5p mimics and inhibitors was assessed by RT-PCR following transfection. (B) The cell proliferation capacity of U251 and U87 cells was assessed by CCK8 assay following transfection with hsa-miR-134-5p mimics and inhibitors. (C) The cell proliferation capacity of U251 and U87 cells was assessed by clonal formation following transfection with hsa-miR-134-5p mimics and inhibitors.
